Thromboprophylaxis with Low-Molecular-Weight Heparins: An Assessment of the Methodological Quality of Studies

Giancarlo Agnelli, Paolo Prandoni, Giovanni Di Minno, Claudio Cimminiello, Francesco Scaglione, Patrizia Boracchi, Mauro Molteni, Hernan Polo Friz, Matteo Nicola Dario Di Minno, Giuseppe Marano

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Low-molecular-weight heparin (LMWH) represents the standard of care for prophylaxis of venous thromboembolism (VTE). We conducted a review of the evidence supporting the use of the different LMWHs employed in VTE prophylaxis, in different clinical settings, and analyzed its progression over time. To evaluate the standards of methodological quality of studies, we elaborated a quality assessment tool. By electronic databases, PubMed, MEDLINE, and Scopus databases, 249 articles deemed eligible for the analysis were selected. Several LMWHs did not have publications in all clinical settings. Extended duration of prophylaxis was documented only for a few LMWH. The quality score yielded statistically significant differences between the medians of the four settings (p = 0.0021) with a higher score in major orthopedic surgery (median, 16; 95% confidence interval [CI], 15-16) when compared with general surgery (median, 14; 95% CI, 13-14; p <0.001). Median score for studies published after the year 1990 was higher than for those published earlier (p <0.001). We conclude that the quality of the studies supporting LMWH for VTE prophylaxis in the different clinical settings is not homogeneous and inferior for studies performed before the year 1990. Clinical interchangeability of LMWHs in clinical practice remains a critical issue, and the selection of a product should be based on evidence available for each agent, and for each clinical indication derived from clinical trials.

Original languageEnglish
Pages (from-to)113-132
Number of pages20
JournalSeminars in Thrombosis and Hemostasis
Volume41
Issue number2
DOIs
Publication statusPublished - 2015

Fingerprint

Low Molecular Weight Heparin
Venous Thromboembolism
Databases
Confidence Intervals
Standard of Care
PubMed
MEDLINE
Orthopedics
Publications
Clinical Trials

Keywords

  • evidence-based practice
  • low-molecular-weight heparin
  • systematic review
  • therapeutic equivalency
  • venous thromboembolism

ASJC Scopus subject areas

  • Hematology
  • Cardiology and Cardiovascular Medicine
  • Medicine(all)

Cite this

Agnelli, G., Prandoni, P., Di Minno, G., Cimminiello, C., Scaglione, F., Boracchi, P., ... Marano, G. (2015). Thromboprophylaxis with Low-Molecular-Weight Heparins: An Assessment of the Methodological Quality of Studies. Seminars in Thrombosis and Hemostasis, 41(2), 113-132. https://doi.org/10.1055/s-0035-1544228

Thromboprophylaxis with Low-Molecular-Weight Heparins : An Assessment of the Methodological Quality of Studies. / Agnelli, Giancarlo; Prandoni, Paolo; Di Minno, Giovanni; Cimminiello, Claudio; Scaglione, Francesco; Boracchi, Patrizia; Molteni, Mauro; Polo Friz, Hernan; Di Minno, Matteo Nicola Dario; Marano, Giuseppe.

In: Seminars in Thrombosis and Hemostasis, Vol. 41, No. 2, 2015, p. 113-132.

Research output: Contribution to journalArticle

Agnelli, G, Prandoni, P, Di Minno, G, Cimminiello, C, Scaglione, F, Boracchi, P, Molteni, M, Polo Friz, H, Di Minno, MND & Marano, G 2015, 'Thromboprophylaxis with Low-Molecular-Weight Heparins: An Assessment of the Methodological Quality of Studies', Seminars in Thrombosis and Hemostasis, vol. 41, no. 2, pp. 113-132. https://doi.org/10.1055/s-0035-1544228
Agnelli, Giancarlo ; Prandoni, Paolo ; Di Minno, Giovanni ; Cimminiello, Claudio ; Scaglione, Francesco ; Boracchi, Patrizia ; Molteni, Mauro ; Polo Friz, Hernan ; Di Minno, Matteo Nicola Dario ; Marano, Giuseppe. / Thromboprophylaxis with Low-Molecular-Weight Heparins : An Assessment of the Methodological Quality of Studies. In: Seminars in Thrombosis and Hemostasis. 2015 ; Vol. 41, No. 2. pp. 113-132.
@article{14d5fb6a5a2640cf9ab5d5d847a4fb42,
title = "Thromboprophylaxis with Low-Molecular-Weight Heparins: An Assessment of the Methodological Quality of Studies",
abstract = "Low-molecular-weight heparin (LMWH) represents the standard of care for prophylaxis of venous thromboembolism (VTE). We conducted a review of the evidence supporting the use of the different LMWHs employed in VTE prophylaxis, in different clinical settings, and analyzed its progression over time. To evaluate the standards of methodological quality of studies, we elaborated a quality assessment tool. By electronic databases, PubMed, MEDLINE, and Scopus databases, 249 articles deemed eligible for the analysis were selected. Several LMWHs did not have publications in all clinical settings. Extended duration of prophylaxis was documented only for a few LMWH. The quality score yielded statistically significant differences between the medians of the four settings (p = 0.0021) with a higher score in major orthopedic surgery (median, 16; 95{\%} confidence interval [CI], 15-16) when compared with general surgery (median, 14; 95{\%} CI, 13-14; p <0.001). Median score for studies published after the year 1990 was higher than for those published earlier (p <0.001). We conclude that the quality of the studies supporting LMWH for VTE prophylaxis in the different clinical settings is not homogeneous and inferior for studies performed before the year 1990. Clinical interchangeability of LMWHs in clinical practice remains a critical issue, and the selection of a product should be based on evidence available for each agent, and for each clinical indication derived from clinical trials.",
keywords = "evidence-based practice, low-molecular-weight heparin, systematic review, therapeutic equivalency, venous thromboembolism",
author = "Giancarlo Agnelli and Paolo Prandoni and {Di Minno}, Giovanni and Claudio Cimminiello and Francesco Scaglione and Patrizia Boracchi and Mauro Molteni and {Polo Friz}, Hernan and {Di Minno}, {Matteo Nicola Dario} and Giuseppe Marano",
year = "2015",
doi = "10.1055/s-0035-1544228",
language = "English",
volume = "41",
pages = "113--132",
journal = "Seminars in Thrombosis and Hemostasis",
issn = "0094-6176",
publisher = "Thieme Medical Publishers",
number = "2",

}

TY - JOUR

T1 - Thromboprophylaxis with Low-Molecular-Weight Heparins

T2 - An Assessment of the Methodological Quality of Studies

AU - Agnelli, Giancarlo

AU - Prandoni, Paolo

AU - Di Minno, Giovanni

AU - Cimminiello, Claudio

AU - Scaglione, Francesco

AU - Boracchi, Patrizia

AU - Molteni, Mauro

AU - Polo Friz, Hernan

AU - Di Minno, Matteo Nicola Dario

AU - Marano, Giuseppe

PY - 2015

Y1 - 2015

N2 - Low-molecular-weight heparin (LMWH) represents the standard of care for prophylaxis of venous thromboembolism (VTE). We conducted a review of the evidence supporting the use of the different LMWHs employed in VTE prophylaxis, in different clinical settings, and analyzed its progression over time. To evaluate the standards of methodological quality of studies, we elaborated a quality assessment tool. By electronic databases, PubMed, MEDLINE, and Scopus databases, 249 articles deemed eligible for the analysis were selected. Several LMWHs did not have publications in all clinical settings. Extended duration of prophylaxis was documented only for a few LMWH. The quality score yielded statistically significant differences between the medians of the four settings (p = 0.0021) with a higher score in major orthopedic surgery (median, 16; 95% confidence interval [CI], 15-16) when compared with general surgery (median, 14; 95% CI, 13-14; p <0.001). Median score for studies published after the year 1990 was higher than for those published earlier (p <0.001). We conclude that the quality of the studies supporting LMWH for VTE prophylaxis in the different clinical settings is not homogeneous and inferior for studies performed before the year 1990. Clinical interchangeability of LMWHs in clinical practice remains a critical issue, and the selection of a product should be based on evidence available for each agent, and for each clinical indication derived from clinical trials.

AB - Low-molecular-weight heparin (LMWH) represents the standard of care for prophylaxis of venous thromboembolism (VTE). We conducted a review of the evidence supporting the use of the different LMWHs employed in VTE prophylaxis, in different clinical settings, and analyzed its progression over time. To evaluate the standards of methodological quality of studies, we elaborated a quality assessment tool. By electronic databases, PubMed, MEDLINE, and Scopus databases, 249 articles deemed eligible for the analysis were selected. Several LMWHs did not have publications in all clinical settings. Extended duration of prophylaxis was documented only for a few LMWH. The quality score yielded statistically significant differences between the medians of the four settings (p = 0.0021) with a higher score in major orthopedic surgery (median, 16; 95% confidence interval [CI], 15-16) when compared with general surgery (median, 14; 95% CI, 13-14; p <0.001). Median score for studies published after the year 1990 was higher than for those published earlier (p <0.001). We conclude that the quality of the studies supporting LMWH for VTE prophylaxis in the different clinical settings is not homogeneous and inferior for studies performed before the year 1990. Clinical interchangeability of LMWHs in clinical practice remains a critical issue, and the selection of a product should be based on evidence available for each agent, and for each clinical indication derived from clinical trials.

KW - evidence-based practice

KW - low-molecular-weight heparin

KW - systematic review

KW - therapeutic equivalency

KW - venous thromboembolism

UR - http://www.scopus.com/inward/record.url?scp=84923858174&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923858174&partnerID=8YFLogxK

U2 - 10.1055/s-0035-1544228

DO - 10.1055/s-0035-1544228

M3 - Article

C2 - 25703242

AN - SCOPUS:84923858174

VL - 41

SP - 113

EP - 132

JO - Seminars in Thrombosis and Hemostasis

JF - Seminars in Thrombosis and Hemostasis

SN - 0094-6176

IS - 2

ER -